Scavenger receptors are a large and diverse
superfamily of
cell surface receptors. Its properties were first recorded in 1970 by Drs. Brown and Goldstein, with the defining property being the ability to bind and remove modified
low density lipoproteins (LDL).[1] Today scavenger receptors are known to be involved in a wide range of processes, such as: homeostasis, apoptosis, inflammatory diseases and pathogen clearance. Scavenger receptors are mainly found on
myeloid cells and other cells that bind to numerous ligands, primarily endogenous and modified host-molecules together with
pathogen-associated molecular patterns(PAMPs), and remove them.[2] The
Kupffer cells in the liver are particularly rich in scavenger receptors, includes SR-A I, SR-A II, and
MARCO.[3]
Function
The scavenger receptor superfamily is defined by its ability to recognize and bind a broad range of common
ligands. These ligands include: polyanionic ligands including lipoproteins, apoptotic cells, cholesterol ester, phospholipids, proteoglycans, ferritin, and carbohydrates.[4] This broad recognition range allows scavenger receptors to play an important role in homeostasis and the combating of diseases. This is accomplished via the recognition of various
PAMP's and
DAMP's, which leads to the removal or scavenging of pathogens with the recognition of PAMP's and the removal of apoptotic cells, self reactive antigens and the products of oxidative stress with the recognition of DAMP's.
In
atherosclerotic lesions,
macrophages that express scavenger receptors on their plasma membrane take up the oxidized LDL deposited in the blood vessel wall aggressively, and develop into
foam cells. Likewise, they secrete various inflammatory
cytokines and accelerate the development of atherosclerosis.
Types
Schematic collection of the scavenger receptor superfamily. Classes A-J are displayed with their respective domains. All classes have a mammalian orthologue, with the exception of C.
Scavenger receptors are incredibly diverse and therefore, organized into many different classes, starting at A and continuing to L.[2] This organization is based on their structural properties. Due to the diversity and ongoing research into scavenger receptors, the receptors lack an accepted
nomenclature and have been described under different names. In 2014 a new nomenclature[5] was proposed that has been used by some researchers, although no official recognition has been given.[6][4]
Members include:Scavenger receptors type 1 (SR-A1), which is a trimer with a molecular weight of about 220-250 kDa (the molecular weight of monomeric protein is about 80 kDa). It preferentially binds modified
LDL, either acylated (acLDL) or oxidized (oxLDL). Other ligands include: β-amyloid, heat shock proteins, surface molecules of Gram-positive and Gram-negative bacteria, hepatitis C virus.
SR-A1 can be alternatively spliced to generate a truncation at the C-terminus; it is contained within the
Endoplasmatic Reticulum, and just like the unspliced version, has a strong affinity for polyanionic ligand binding.
SCARA1 or
MSR1 (SR-A1): besides macrophages they can be found on smooth vascular muscle cells and
endothelial tissues; oxidative stress enhances their presence on the endothelium.
SCARA2 or
MARCO (SR-A6): only found on macrophages in the peritoneum, lymph nodes, liver and specific zones of the spleen. Bacteria and lipopolysaccharide produced by bacteria stimulate its expression; SR-A6 is unable to connect with modified LDL.
SCARA3, MSRL1 or APC7 (SR-A3): plays a significant role in the protection against reactive oxygen species (
ROS).
SCARA4 or
COLEC12 (SR-A4): acts as a receptor for the detection, engulfment and destruction of oxidatively modified LDL for vascular endothelial cells.
SCARA5 or TESR (SR-A5): located in a diverse set of tissues, such as, lung placenta, intestine, heart and epithelial cells, it has a high affinity for bacteria but not for modified LDL.
Class B
CD36 and
scavenger receptor class BI are identified as genes encoding for oxidized LDL receptors and classified into scavenger receptor B (SR-B). Both proteins have two transmembrane domains with an extracellular loop, and they are concentrated in a specific
plasma membrane microdomain, the
caveolae.
Members include:
SCARB1 or CD36L1 (SR-B1): can interact not only with oxidized LDL but also with normal
LDL and high-density lipoproteins (
HDL), and plays an important role in their transportation into the cells. Recent studies have indicated that SR-B1 is likely to be the major receptor involved in
HDL metabolism in mice and humans.[8][9] Besides LDL and HDL, SR-B1 binds to viruses and bacteria. SR-B1 is located on hepatocytes, steroidogenic cells, arterial wall and macrophages. Mutations in SR-B1 have a negative effect on fertility and innate immune response, and leads to an increase in atherosclerosis.
SCARB3 or
CD36 (SR-B2): has been thought to be implicated in
cell adhesion, development of blood vessels, in the
phagocytosis of apoptotic cells, and in the
metabolism of long-chain
fatty acids. Furthermore, it has been shown that CD36 is heavily involved with macrophage migration and signalling, together with protecting the host against, bacteria, fungi and malaria parasites. In experimental mice models of atherosclerosis, in which the gene for CD36 has been deleted, the mice have a greatly reduced number of atherosclerotic lesions.[10] CD36 can be found in many different cells, for example, insulin-responsive cells, hematopoietic cells like platelets, monocytes, and macrophages, endothelial cells, and specialized epithelial cells in the breast and the eye.
Other
Some receptors that can bind to oxidized LDL have been discovered.
Mucin is a naturally occurring viscous substance (such as found in many nattō or
okra) that is composed of a protein and covalently linked polysaccharides. A Drosophila class C scavenger receptor (dSR-C1) also has a
mucin-like structure.
Lectin-like oxidized LDL receptor-1 (
LOX-1) was isolated from an aortic
endothelial cell; recently, it has been discovered in
macrophages and vascular
smooth muscle cells in artery vessels. The expression of LOX-1 is induced by inflammatory stimuli, so LOX-1 is thought to be involved in the development of
atherosclerotic lesions.[11]
^Khovidhunkit W (April 2011). "A genetic variant of the scavenger receptor BI in humans". The New England Journal of Medicine. 364 (14): 1375–6, author reply 1376.
doi:
10.1056/nejmc1101847.
PMID21470028.